MADRIGAL PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2016 to Q3 2024.
  • Madrigal Pharmaceuticals, Inc. Interest Expense for the quarter ending September 30, 2024 was $3.68M, a 4.99% increase year-over-year.
  • Madrigal Pharmaceuticals, Inc. Interest Expense for the twelve months ending September 30, 2024 was $15.1M, a 45.3% increase year-over-year.
  • Madrigal Pharmaceuticals, Inc. annual Interest Expense for 2023 was $12.7M, a 221% increase from 2022.
  • Madrigal Pharmaceuticals, Inc. annual Interest Expense for 2022 was $3.96M.
  • Madrigal Pharmaceuticals, Inc. annual Interest Expense for 2021 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $15.1M $3.68M +$175K +4.99% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $15M $3.66M +$755K +26% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $14.2M $3.84M +$1.5M +64.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $12.7M $3.97M +$2.29M +136% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $10.4M $3.5M +$2M +133% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $8.42M $2.9M +$2.12M +272% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $6.3M $2.34M +$2.34M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $3.96M $1.68M +$1.68M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $2.28M $1.5M +$1.5M Jul 1, 2022 Sep 30, 2022 10-K 2024-02-28
Q2 2022 $780K $780K +$780K Apr 1, 2022 Jun 30, 2022 10-K 2024-02-28
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-K 2024-02-28
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-03
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-K/A 2023-03-03
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-K/A 2023-03-03
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-K/A 2023-03-03
Q2 2016 $238K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $975K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.